These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22473725)

  • 21. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bath salts: an emerging danger.
    Gallucci G; Malik M; Kahn S; Afzal N; Trimzi I
    Del Med J; 2011 Nov; 83(11):357-9; quiz 360. PubMed ID: 22372121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Bath salts": a new drug epidemic-a case report.
    Lajoie TM; Rich A
    Am J Addict; 2012; 21(6):572-3. PubMed ID: 23082840
    [No Abstract]   [Full Text] [Related]  

  • 24. Multi-organ dysfunction due to bath salts: are we aware of this entity?
    Valsalan R; Varghese B; Soman D; Buckmaster J; Yew S; Cooper D
    Intern Med J; 2017 Jan; 47(1):109-111. PubMed ID: 28076917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bath salts: they are not what you think.
    Wieland DM; Halter MJ; Levine C
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):17-21. PubMed ID: 22439144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
    German CL; Fleckenstein AE; Hanson GR
    Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two cases of disseminated intravascular coagulation due to "bath salts" resulting in fatalities, with laboratory confirmation.
    Young AC; Schwarz ES; Velez LI; Gardner M
    Am J Emerg Med; 2013 Feb; 31(2):445.e3-5. PubMed ID: 22867829
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthetic cathinones (bath salts): legal status and patterns of abuse.
    Fass JA; Fass AD; Garcia AS
    Ann Pharmacother; 2012 Mar; 46(3):436-41. PubMed ID: 22388331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
    Zawilska JB; Słomiak K; Wasiak M; Woźniak P; Massalski M; Krupa E; Wojcieszak JŁ
    Przegl Lek; 2013; 70(6):386-91. PubMed ID: 24052975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The development from drug to designer drug].
    Askaa B; Horwitz H; Wøien VA; Høgberg LC; Jürgens G
    Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral pharmacology of designer cathinones: a review of the preclinical literature.
    Gregg RA; Rawls SM
    Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermia and multiorgan failure after abuse of "bath salts" containing 3,4-methylenedioxypyrovalerone.
    Borek HA; Holstege CP
    Ann Emerg Med; 2012 Jul; 60(1):103-5. PubMed ID: 22387085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute psychosis induced by bath salts: a case report with clinical and forensic implications.
    Stoica MV; Felthous AR
    J Forensic Sci; 2013 Mar; 58(2):530-3. PubMed ID: 23317451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Bath salts" intoxication.
    Ross EA; Watson M; Goldberger B
    N Engl J Med; 2011 Sep; 365(10):967-8. PubMed ID: 21899474
    [No Abstract]   [Full Text] [Related]  

  • 36. [New psychoactive substances and their prevalence in the Czech Republic].
    Mravčík V; Běláčková V; Grohmannová K; Zábranský T
    Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.
    Thornton SL; Gerona RR; Tomaszewski CA
    J Med Toxicol; 2012 Sep; 8(3):310-3. PubMed ID: 22528592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin syndrome associated with MDPV use: a case report.
    Mugele J; Nañagas KA; Tormoehlen LM
    Ann Emerg Med; 2012 Jul; 60(1):100-2. PubMed ID: 22237165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.
    Szily E; Bitter I
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):223-31. PubMed ID: 24380963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.